|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-6-28
|
|
pubmed:abstractText |
To assess the toxicity and the efficacy of preoperative radiotherapy with continuous infusion 5-fluorouracil (5-FU) for locally advanced adenocarcinoma of the rectum.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
883-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11429215-Adenocarcinoma,
pubmed-meshheading:11429215-Adult,
pubmed-meshheading:11429215-Aged,
pubmed-meshheading:11429215-Aged, 80 and over,
pubmed-meshheading:11429215-Antimetabolites, Antineoplastic,
pubmed-meshheading:11429215-Combined Modality Therapy,
pubmed-meshheading:11429215-Confidence Intervals,
pubmed-meshheading:11429215-Diarrhea,
pubmed-meshheading:11429215-Female,
pubmed-meshheading:11429215-Fluorouracil,
pubmed-meshheading:11429215-Humans,
pubmed-meshheading:11429215-Male,
pubmed-meshheading:11429215-Middle Aged,
pubmed-meshheading:11429215-Neoplasm Staging,
pubmed-meshheading:11429215-Postoperative Complications,
pubmed-meshheading:11429215-Radiotherapy Dosage,
pubmed-meshheading:11429215-Rectal Neoplasms
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
|
|
pubmed:affiliation |
Peter MacCallum Cancer Institute, Victoria, Melbourne, Australia. sngan@petermac.unimelb.edu.au
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
